Real-World Examples of Decentralized Clinical Trials Using Remote Monitoring

Decentralized Clinical Trials (DCTs) are rapidly reshaping how clinical research is conducted. At the core of this evolution lies Remote Patient Monitoring (RPM), enabling continuous, real-time data collection from participants, irrespective of geographic location. From wearables to telemedicine, RPM technologies are being adopted in both interventional and observational trials. This article provides real-world case studies of DCTs utilizing remote monitoring, illustrating how sponsors are improving patient engagement, accelerating timelines, and maintaining regulatory compliance.

1. Verily’s Project Baseline – Heart Health Study

Overview: Verily, a subsidiary of Alphabet Inc., launched Project Baseline, an extensive research platform that includes the Heart Health Study.

• Technology Used: Fitbit devices for continuous heart rate, activity, and sleep tracking
• Study Objective: To assess cardiovascular risk and predict adverse cardiac events
• RPM Use: Collected 24/7 physiological data remotely, analyzed trends and deviations

The trial reduced the number of in-person visits, instead relying on virtual touchpoints and remote data access. All patient data was reviewed through centralized dashboards.

2. Janssen’s CHIEF-HF Trial – Mobile-Based Heart Failure Study

Overview: Janssen conducted the CHIEF-HF study to evaluate canagliflozin in heart failure patients using a completely decentralized model.

• Technology Used: Fitbit, mobile app for ePRO collection, eConsent tools
• Remote Monitoring: Activity levels, heart rate, step count
• Significance: No physical site visits were required during the study

Patients completed all trial tasks from home. This model was deemed highly efficient in reaching a broader, more diverse population and ensuring SOP compliance pharma.

3. Pfizer’s BlueSky COVID-19 Vaccine Monitoring

Overview: During the pandemic, Pfizer launched decentralized components within its COVID-19 vaccine trials.

• Tools Used: eDiary, wearable thermometers, mobile symptom trackers
• RPM Data: Temperature, self-reported symptoms, adverse events
• Purpose: To monitor participants post-vaccination remotely

This approach allowed real-time adverse event tracking and reduced on-site monitoring needs while complying with stability testing protocols related to cold-chain compliance.

4. Otsuka & Click Therapeutics – Digital Therapeutics DCT

Overview: This trial tested a digital therapeutic for Major Depressive Disorder using a fully virtual setup.

• Tech Stack: Wearables + cognitive behavioral therapy via app
• Participant Oversight: Monitored remotely for behavioral improvement, adherence
• Remote Alerts: Triggered based on in-app behavior patterns

One key benefit was real-time patient engagement and clinician interaction, which enhanced adherence and reduced dropouts.

5. GSK’s DCT for Asthma Using Smart Inhalers

Overview: GSK partnered with Propeller Health to incorporate smart inhalers in an asthma trial.

• Remote Data: Inhaler use frequency, geo-location, environmental triggers
• Goal: Improve real-world evidence generation and inhaler adherence

The smart inhalers communicated data directly to trial databases, allowing investigators to identify usage gaps and intervene early via telemedicine.

6. Eli Lilly – Rheumatoid Arthritis DCT with Wearables

Overview: A hybrid decentralized model was used for an RA study, integrating wearables and ePROs.

• Monitoring Tools: Step counters, pain level reporting via mobile app
• Analysis: Correlation between physical activity and symptom flare-ups

This model allowed for adaptive design changes and reduced protocol deviations across sites.

7. Takeda – Oncology RPM Trial

Overview: Takeda ran an oncology trial where patients wore wearable patches to monitor vitals at home.

• Monitoring: Heart rate, body temperature, respiration
• Key Benefit: Minimized patient burden and improved safety monitoring

The patches flagged serious adverse events early, ensuring rapid intervention in compliance with computer system validation protocols.

8. Apple & Johnson & Johnson – Heartline Study

Overview: A massive virtual study investigating atrial fibrillation risk using Apple Watch data.

• Enrollment: Over 100,000 participants via digital recruitment
• RPM Use: ECG monitoring, heart rhythm tracking, step count

This trial exemplified a consumer device’s role in regulated research and demonstrated that large-scale DCTs are both feasible and effective.

9. BMS & Evidation – MS and Fatigue Study

Overview: BMS explored fatigue in Multiple Sclerosis patients using digital health apps.

• Remote Capture: Symptom journaling, cognitive test gamification
• Monitoring Outcome: Functional improvements over time

Data captured remotely offered rich behavioral insights into MS progression, supporting pharma regulatory endpoints.

What Makes These DCTs Successful?

• Early integration of digital tools into protocol design
• Emphasis on participant onboarding and remote training
• Validated wearable and RPM devices per USFDA standards
• Clear escalation protocols for remote alerts
• Use of centralized monitoring and risk-based approaches

Conclusion:

These real-world examples showcase the diversity and effectiveness of remote patient monitoring in decentralized clinical trials. Whether it’s chronic disease management, post-vaccination monitoring, or behavioral health studies, RPM tools are transforming the research landscape. With the right technologies, validated systems, and training, DCTs offer a more inclusive, efficient, and patient-friendly future for clinical trials. As RPM adoption grows, regulatory guidance and GMP audit checklists must evolve to reflect these modern methodologies.